COMORBIDITY OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND ISCHEMIC HEART DISEASE: DISTRIBUTION AND RISK FACTORS OF SEVERE COMPLICATIONS (literature review)
Keywords:
chronic obstructive pulmonary disease, ischemic heart disease, comorbidity, arrhythmia, angina pectoris, myocardial infarctionAbstract
Despite the fact that the comorbidity of chronic obstructive pulmonary disease (COPD) and coronary heart disease (CHD) has been widely studied in world medicine, it remains relevant today in the context of environmental factors, changing lifestyles, common risk factors, and increased mortality from both diseases. The high prevalence of the disease directly indicates an increase in disability and mortality from it.
References
Adeloye D, Chua S, Lee C, et al. Global and regional estimates of COPD prevalence: Systematic review and meta-analysis. J Glob Health. 2015;5(2):020415. doi:10.7189/jogh.05-020415.
Agustí, A.; Celli, B. Natural history of COPD: Gaps and opportunities ERJ Open Res 2017, 3, 117–2017.
Avci Е., Avci G.A. Important biomarkers that play a role in the chronic obstructive pulmonary disease process. J. Med. Biochem. 2018; 37 (1): 46–53. DOI: 10.1515/jomb-2017- 0035.
Axson EL, Sundaram V, Bloom CI, Bottle A, Cowie MR, Quint JK. Temporal Trends in the Incidence of Heart Failure among Patients with Chronic Obstructive Pulmonary Disease and Its Association with Mortality. Ann Am Thorac Soc. 2020 Aug;17(8):939-948. doi: 10.1513/AnnalsATS.201911-820OC. PMID: 32275836.
Barnes, P.J. Mechanisms of development of multimorbidity in the elderly Eur. Respir. J 2015, 45, 790–806.
Campo G, Pavasini R, Malagù M, Mascetti S, Biscaglia S, Ceconi C, Papi A, Contoli M. Chronic obstructive pulmonary disease and ischemic heart disease comorbidity: overview of mechanisms and clinical management. Cardiovasc Drugs Ther. 2015 Apr;29(2):147-57. doi: 10.1007/s10557-014-6569-y. PMID: 25645653.
Campo G., Pavasini R., Malagu M. et al. Relationship between troponin elevation, cardiovascular history and adverse events in patients with acute exacerbation of COPD. 2015; 12(5): 560–67. https://dx.doi.org/10.3109/15412555.2014.995293.
Cazzola M, Rogliani P, Matera MG. Cardiovascular disease in patients with COPD. Lancet Respir Med. 2015;3(8):593–595. doi: 10.1016/S2213-2600(15)00279-9.16.
Gaynitdinova V.V., Avdeev S.N., Neklyudova G.V., Nuralieva G.S., Baytemerova I.V. An impact of cardiovascular comorbidity on course and prognosis of chronic obstructive pulmonary disease. Pulmonologiya. 2019;29(1):35-42. (In Russ.) https://doi.org/10.18093/0869-0189-2019-29-1-35-42.
GBD 2015 Chronic Respiratory Disease Collaborators. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir Med. 2017;5(9):691-706. doi:10.1016/S2213-2600(17)30293-X.
Global Initiative Chronic Obstructive Pulmonary Disease. Global Strategy for Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. 2018 Report. Abailable at: https://goldcopd.org/wp-content/uploads/2017/11/GOLD-2018-v6.0-FINAL-revised-20- Nov_WMS.pdf 17.
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Global Initiative for Chronic Obstructive Lung Disease (GOLD). The updated 2017 report is available at: www.goldcopd.com.
Groenewegen A, Zwartkruis VW, Smit LJ, de Boer RA, Rienstra M, Hoes AW, Hollander M, Rutten FH. Sex-specific and age-specific incidence of ischaemic heart disease, atrial fibrillation and heart failure in community patients with chronic obstructive pulmonary disease. BMJ Open Respir Res. 2022 Dec;9(1):e001307. doi: 10.1136/bmjresp-2022-001307. PMID: 36585036; PMCID: PMC9809303.
Ho T-W, Huang C-T, Ruan S-Y, Tsai Y-J, Lai F, Yu C-J (2017) Diabetes mellitus in patients with chronic obstructive pulmonary disease-The impact on mortality. PLoS ONE 12(4): e0175794. https://doi.org/10.1371/journal.pone.0175794.
https://www.who.int/ru/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd).
Kim BG, Lee H, Kang MG, Kim JS, Moon JY. Risk of Ischemic Heart Disease in Chronic Obstructive Pulmonary Disease: A Nationwide Cohort Study. J. Korean Med Sci. 2023 Oct 30;38(42): e344. doi: 10.3346/jkms.2023.38.e344. PMID: 37904657; PMCID: PMC10615639.
Kubysheva N.I., Soodaeva S.K., Postnikova L.B., Kuzmina E.I., Kontorshchikova K.N., Klimanov I.A. Study of indicators of oxidative stress in patients with exacerbation of chronic obstructive pulmonary disease. Pulmonology. 2019; 29 (6): 708–715. DOI: 10.18093/0869-0189-2019-29-6-708-715
Maselli DJ, Bhatt SP, Anzueto A, Bowler RP, DeMeo DL, Diaz AA, Dransfield MT, Fawzy A, Foreman MG, Hanania NA, Hersh CP, Kim V, Kinney GL, Putcha N, Wan ES, Wells JM, Westney GE, Young KA, Silverman EK, Han MK, Make BJ. Clinical Epidemiology of COPD: Insights From 10 Years of the COPDGene Study. Chest. 2019 Aug;156(2):228-238. doi: 10.1016/j.chest.2019.04.135. Epub 2019 May 30. PMID: 31154041; PMCID: PMC7198872.
Meng K, Zhang X, Liu W, Xu Z, Xie B, Dai H. Prevalence and Impact of Chronic Obstructive Pulmonary Disease in Ischemic Heart Disease: A Systematic Review and Meta-Analysis of 18 Million Patients. Int J Chron Obstruct Pulmon Dis. 2024 Oct 22;19:2333-2345. doi: 10.2147/COPD.S474223. PMID: 39465033; PMCID: PMC11512537.
Morgan AD, Rothnie KJ, Bhaskaran K, et al. Chronic obstructive pulmonary disease and the risk of 12 cardiovascular diseases: a population-based study using UK primary care data Thorax 2018;73:877-879.
Prudente R., Franco E.A.T., Mesquita C.B. et al. Predictors of mortality in patients with COPD after 9 years. Int J Chron Obstruct Pulmon Dis. 2018; 13: 3389–98. https://dx.doi.org/10.2147/COPD.S174665.
Rasmussen T, Køber L, Pedersen JH, Dirksen A, Thomsen LH, Stender S, Brodersen J, Groen J, Ashraf H, Kofoed KF. Relationship between chronic obstructive pulmonary disease and subclinical coronary artery disease in long-term smokers. Eur Heart J Cardiovasc Imaging. 2013 Dec;14(12):1159-66. doi: 10.1093/ehjci/jet057. Epub 2013 May 2. PMID: 23639550.
Roversi S, Fabbri LM, Sin DD, et al. Chronic obstructive pulmonary disease and cardiac diseases. An urgent need for inte-grated care. Am J Respir Crit Care Med. 2016;194(11):1319 –1336. doi: 10.1164/rccm.201604-0690SO.
Santos NCD, Miravitlles M, Camelier AA, Almeida VDC, Maciel RRBT, Camelier FWR. Prevalence and Impact of Comorbidities in Individuals with Chronic Obstructive Pulmonary Disease: A Systematic Review. Tuberc Respir Dis (Seoul). 2022 Jul;85(3):205-220. doi: 10.4046/trd.2021.0179. Epub 2022 May 27. PMID: 35618259; PMCID: PMC9263346.
Арутюнов А.Г., Драгунов Д.О., Арутюнов Г.П., Рылова А.К., Пашкевич Д.Д., Витер К.В. и др. Первое открытое исследование синдрома острой декомпенсации сердечной недостаточности и сопутствующих заболеваний в Российской Федерации. Независимый регистр ОРАКУЛ-РФ. Кардиология. 2015;55(5):12-21]
Григорьева Н.Ю., Майорова М.В., Королёва М.Е., Самолюк М.О. Особенности формирования и развития сердечно-сосудистых заболеваний у больных хронической обструктивной болезнью легких // Терапевтический архив. 2019. №1. URL: https://cyberleninka.ru/article/n/osobennosti-formirovaniya-i-razvitiya-serdechno-sosudistyh-zabolevaniy-u-bolnyh-hronicheskoy-obstruktivnoy-boleznyu-legkih (дата обращения: 04.08.2025).
Ефремова О.А., и др. Роль хронической обструктивной болезни легких в развитии полиморбидной патологии // Научный результат. Сер. Медицина и фармация. - 2016. - Т.2, №4.-С. 13-18. - DOI: 10.18413/2313-8955-2016-2-4-13-18.
Игнатова Г.Л., Антонов В.Н., Родионова О.В. Нарушения функции внешнего дыхания при сочетанном течении ХОБЛ и ИБС. Consilium Medicum. 2014; 16 (11): 28–32.
Кароли Н.А., Бородкин А.В., Ребров А.П. Факторы риска развития неблагоприятных исходов у пациентов с хронической обструктивной болезнью легких //Терапия. - 2022. - №5. - С. 18-25. https://dx.doi.org/10.18565/therapy.2022.5.18-25
Прозорова Г.Г., Агапова Ю.Р., Фатеева О.В., Трибунцева Л.В. Влияние коморбидности на течение хронической обструктивной болезни легких //Научно-медицинский вестник Центрального Черноземья. 2022. №. URL: https://cyberleninka.ru/article/n/vliyanie-komorbidnosti-na-techenie-hronicheskoy-obstruktivnoy-bolezni-legkih (дата обращения: 03.08.2025).
Трисветова Е.Л. Коморбидность при хронической обструктивной болезни легких // Медицинские новости. 2023. №11 (350). URL: https://cyberleninka.ru/article/n/komorbidnost-pri-hronicheskoy-obstruktivnoy-bolezni-legkih (дата обращения: 03.08.2025).
Фуштей И. М. Влияние хронической обструктивной болезни легких на клинико-функциональное состояние миокарда у больных ишемической болезнью сердца / И. М. Фуштей, С.Л. Подсевахина, А.И. Паламарчук, О.В. Ткаченко, Е.С. Чабанная // Семейная медицина. - 2018. - № 1.-С. 73-76. - Режим доступу: http://nbuv.gov.ua/UJRN/simmed_2018_1_15.
Чаулин А.М., Дупляков Д.В. Коморбидность хронической обструктивной болезни легких и сердечно-сосудистых заболеваний. Кардиоваскулярная терапия и профилактика. 2021;20(3):2539. https://doi.org/10.15829/1728-8800-2021-2539.
